Kevin BULKMANS SRL
Kevin BULKMANS reported total assets of €1.93m at the end of the 2025 financial year (annual accounts filed with the NBB on 13 Aug 2026).
The score of Kevin BULKMANS shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +74 % Total assets +20 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Kevin BULKMANS's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 13 Aug 2026
- Year ended 31 Dec 2024filed on 20 Aug 2025
- Year ended 31 Dec 2023filed on 21 Aug 2024
- Year ended 31 Dec 2022filed on 24 Aug 2023
- Year ended 31 Dec 2021filed on 16 Aug 2022
Kevin BULKMANS's financial analysis
- Solvency58.0%sector median: 44.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Kevin BULKMANS
Kevin BULKMANS's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0835.826.234
- VAT number
- BE0835826234
- Peppol
- Registered · 0208:0835826234 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 28 Apr 2011
- Registered office
- 9140 Temse
- Latest accounts
- 2025 · filed on 13 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Kevin BULKMANS (SRL) has been based in Temse since 2011, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 214,039 € and equity of €1.12m; its revenue is not published. Its solvency stands at 58.0%, above the median of its sector (44.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Kevin BULKMANS
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie de Neef - Duez Retail sale of pharmaceutical products Mons · balance sheet 181,026 €
- APOTEEK P. Sergeant Retail sale of pharmaceutical products Anderlecht · balance sheet €1.95m
- JUVO Retail sale of pharmaceutical products Oudenburg · balance sheet €1.89m
- Gans Investors Retail sale of pharmaceutical products Scherpenheuvel-Zichem · balance sheet €1.97m
- De VOS Pharma Retail sale of pharmaceutical products Balen · balance sheet €2.00m
- Apotheek Kortessem Retail sale of pharmaceutical products Hasselt · balance sheet €1.86m
- Asapharm Retail sale of pharmaceutical products Gembloux · balance sheet €1.86m
- Fayser Retail sale of pharmaceutical products Pont-à-Celles · balance sheet €1.85m
Frequently asked questions about Kevin BULKMANS
What is the revenue of Kevin BULKMANS?
Kevin BULKMANS files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Kevin BULKMANS?
In Belgium, the VAT number is the company number prefixed with BE: BE0835826234 for Kevin BULKMANS, if the company is VAT-registered. Its company number (CBE) is 0835.826.234.
Where is the registered office of Kevin BULKMANS?
According to the CBE register, the registered office of Kevin BULKMANS is in 9140 Temse.
What is the equity of Kevin BULKMANS?
At the close of the 2025 financial year, the equity of Kevin BULKMANS amounts to 1,119,071 €, a solvency of 58.0% of total assets.
Who manages Kevin BULKMANS?
The register lists 1 active mandates at Kevin BULKMANS. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Kevin BULKMANS
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →